Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.49 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13001768 | 1.00 | CASP1 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| SCHEMBL14200056 | 1.00 | CASP1 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| Carisbamate SCHEMBL2425732 | 0.83 | AOC3 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| Carisbamate SCHEMBL729003 | 0.83 | AOC3 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| Carisbamate SCHEMBL1037665 | 0.83 | AOC3 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| Carisbamate SCHEMBL8741032 | 0.83 | ADRB2 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| Carisbamate SCHEMBL8741086 | 0.83 | ADRB2 (0.49) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| SCHEMBL27830249 | 0.81 | SMN1; SMN2 (0.44) | CASP1ADRB2ADRB1ALDH1A1ADRB3 | |
| SCHEMBL8187818 | 0.81 | CASP1 (0.43) | CASP1ADRB2ADRB1AOC3CYP2D6 | |
| SCHEMBL8395836 | 0.81 | CASP1 (0.43) | CASP1ADRB2ADRB1AOC3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103068383-A | Methods for the treatment or prophylaxis of thrombosis or embolism | IPCA LAB LTD | 2013-04-24 | — | — | CN | disclosed |
| US-20080090903-A1 | PHENYLALKYL CARBAMATE COMPOSITIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090903-A1 | PHENYLALKYL CARBAMATE COMPOSITIONS | CA2, PKD2, PKD1 | CASP1 852/4885ADRB2 4400/4885ADRB1 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.